MEYLE E.; OTTO H. H., ARCH. PHARM., 320,(1987) 571-574
作者:MEYLE E.、 OTTO H. H.
DOI:——
日期:——
NOVEL SEH INHIBITORS AND THEIR USE
申请人:Smithkline Beecham Corporation
公开号:EP2097378A1
公开(公告)日:2009-09-09
US6448443B1
申请人:——
公开号:US6448443B1
公开(公告)日:2002-09-10
[EN] SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS<br/>[FR] SYNTHESE COMBINATOIRE D'ECHANTILLOTHEQUES DE COMPOSES REMINISCENTS DE PRODUITS NATURELS
申请人:HARVARD COLLEGE
公开号:WO2000006525A2
公开(公告)日:2000-02-10
The present invention provides complex compounds reminiscent of natural products and libraries thereof, as well as methods for their production. The inventive compounds and libraries of compounds are reminiscent of natural products in that they contain one or more stereocenters, and a high density and diversity of functionality. In general, the inventive libraries are synthesized from diversifiable scaffold structures, which are synthesized from readily available or easily synthesizable template structures. In certain embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from a shikimic acid based epoxyol template. In other embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from the pyridine-based template isonicotinamide. The present invention also provides a novel ortho-nitrobenzyl photolinker and a method for its synthesis. Furthermore, the present invention provides methods and kits for determining one or more biological activities of members of the inventive libraries. Additionally, the present invention provides pharmaceutical compositions containing one or more library members.
[EN] NOVEL SEH INHIBITORS AND THEIR USE<br/>[FR] NOUVEAUX INHIBITEURS DE SEH ET UTILISATION DE CES DERNIERS
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2008105968A1
公开(公告)日:2008-09-04
[EN] The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. [FR] La présente invention concerne de nouveaux inhibiteurs de sEH et l'utilisation de ces derniers dans le traitement de maladies médiées par l'enzyme sEH.